The riluzole patient group exhibited an average upper extremity motor score (UEMS) gain 1.8 times higher than the placebo group, albeit this difference did not reach statistical significance.
1
—
—
The riluzole patient group exhibited an average upper extremity motor score (UEMS) gain 1.8 times higher than the placebo group, albeit this difference did not reach statistical significance.